Based on our data, TP53 and MAP2K1 shared a highly significant pattern of concurrent mutations, while EGFR and KRAS exhibited a pattern of mutually exclusive mutations (Fig 2 d).
← all excerpts
Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma.
1
—
—